A venture fund meets a company through many doors, and several of them come with someone else's confidentiality terms attached. This guide is for the general counsel's office, or the person who liaises between it and the platform team, on the day a partner says "I know a company that would fit" and the honest follow-up is "how do you know?"
Whose terms are these, and whom do they bind?
Third-party confidentiality terms sit in four places around a referral, and each points to a different reviewer.
- Terms you owe the company. An investor's information rights can arrive with duties. NVCA's model management rights letter, for example, makes confidential information an investor receives or learns under the letter "subject to the confidentiality provisions set forth in that certain Investors' Rights Agreement", so the clause that binds you may live in a different document from the one in your file.
- Terms you owe someone else about the company: a banker's or seller's process NDA, a co-investor's or lender's information, a client engagement. If the restriction sits in your own engagement contract, the client-contract escalation brief covers it.
- Terms the company owes others about its records: customer contracts, vendor terms, employee privacy. SourceX's who-qualifies page treats this as a rights question; its screening profile reads: "The company owns the material, or can license it without breaching client confidentiality, employee privacy or third-party contracts." Its trust page says the rights review covers "any customer or vendor contract limits" and that the supplier confirms its rights in the agreement.
- Terms SourceX owes others. The sample agreement says the Acquisition Partner's identity and contract may remain confidential, and section 7 of the program terms says partners never receive confidential buyer information. There is nothing for you to manage here except the urge to guess.
Your own agreement with SourceX does not sort any of this out. Section 8 of the terms says the signed Channel Partner Agreement governs confidentiality between you and SourceX. Section 2.4 of the sample adds: "It does not bind a contact that is not a party to it." And section 7.8 keeps any NDA you separately signed with SourceX in force within its scope "unless expressly replaced in writing".
What the introduction needs, and who may receive it
An introduction serves two decisions. The CEO decides whether the company talks to SourceX. SourceX decides whether the introduction is credited and whether the company fits. Neither decision needs anything you learned under someone else's terms.
| Recipient | May receive | Never receives |
|---|---|---|
| The company's CEO | SourceX's published facts, your reward disclosure and one question: does the company want the conversation? | Anything you received under another party's terms |
| SourceX | The record section 3.3 of the sample describes (company, domain, partner, opportunity, method, timestamps), once the CEO agrees | Records, contracts, inventories, NDAs or anything learned under them |
| Your counsel | The terms themselves and an honest account of how you came to know the company | Nothing held back |
| Colleagues | That an introduction is under review, on a need-to-know basis | The underlying materials |
| The public | Nothing about the company | Every line, unless the steps in the publication approval guide are complete |
Section 4.2 of the sample is the backstop: "This Agreement gives Partner no authority to share a supplier's inventory, records, raw data or personal information, or to access extraction systems." The company describes itself when it applies, and SourceX's process page says no files are shared at that stage.
The counsel escalation trigger sheet
Each trigger is something a partner notices. When it appears, the column on the right says what may still happen while the right person reads the terms.
| # | Trigger you notice | Whose terms | Who reads them | What pauses | What may continue meanwhile |
|---|---|---|---|---|---|
| 1 | You first heard of the company inside a sale or financing process | The process NDA your fund signed | Your counsel | Any mention of the company in a referral setting, to anyone | Nothing that depends on the process |
| 2 | Your fund holds information rights or a board seat | Investor-rights confidentiality, which may be incorporated from another agreement | Your fund counsel | Any use of what you learned there | One question to that CEO; it goes nowhere else and never reaches another company |
| 3 | A co-investor, LP or lender shared a memo about the company | The sharer's terms with you | Your counsel | Any use of the memo | Only a path built from public facts and the CEO's own words |
| 4 | Your engagement contract with the company limits introductions | Your contract | Your firm's counsel | The introduction | The client-contract brief linked above |
| 5 | The CEO says customer contracts carry confidentiality or data-use clauses | The company's contracts | The company's counsel; SourceX's rights review | Nothing on your side, as long as you never read or forward them | The introduction, if the CEO wants it |
| 6 | The records hold other businesses' information, such as a service firm's client files | The company's client agreements | The company's counsel | Any view from you on fit | The CEO can ask SourceX directly |
| 7 | Someone offers you a contract, an NDA or records "to help" | Whoever wrote them | Your counsel, under your own policy | Receiving or forwarding anything | The unasked-files procedure |
| 8 | The company asks you to sign an NDA before discussing SourceX | The proposed NDA | Your counsel, before you sign | Any detailed discussion | The CEO can apply to SourceX itself |
Method note. The triggers apply the unsigned sample Channel Partner Agreement, the program terms (version 2026-10-22.2, since replaced by version 2026-11-04), SourceX's who-qualifies, trust and process pages, and NVCA's model management rights letter, all read on 2026-10-28. They describe who reviews what; none predicts what counsel will decide, and none is legal advice. We chose the eight situations because each one puts a third party's terms between the partner and the CEO. No data on how often they occur has been published.
Cut the context down to what the next decision needs
The safest referral carries the least. If what makes a company look promising came from a data room, a board pack or a co-investor's memo, that reason cannot appear anywhere: not in the email to the CEO, not in the introduction record, not in a note to a colleague. Rebuild the ask from scratch. The CEO hears what SourceX publishes about fit and process, hears that you may be paid, and is asked one thing: whether the company wants to explore licensing its own operating records.
The question of what may prompt that one question at all, as opposed to what may be said in it, is worked through in the boundary between public signals and private board knowledge.
Escalation, withdrawal and publication are three separate calls
Escalation. Counsel's answer may be yes, no, or "only by a different route". Record the answer and the date, not the reasoning, in the referral file.
Withdrawal. If counsel says stop after an introduction was submitted, tell SourceX you are withdrawing it and say nothing about the terms behind the decision. The published terms do not say how a withdrawn introduction is recorded or what it means for credit later; SourceX decides. Tell the CEO only that you are not in a position to continue.
Publication. Material received under someone else's terms never appears in anything you publish, and neither does the fact that a company was considered.
Three cases (Illustrative)
Illustrative: invented funds and companies, no outcome implied.
The deal the fund passed on. A fund evaluated a 260-person insurance services firm under a banker's NDA and declined to invest. A year later a partner thinks its claims archive would suit a data license. Trigger 1 applies. Counsel reads the NDA and tells the partner nothing learned in the process may be used. The fund takes no step. If the CEO later raises data licensing with the fund on their own initiative, the partner returns to counsel before answering.
The co-investor's memo. A co-investor's quarterly memo mentions that a shared portfolio company has twelve years of dispatch records. Trigger 3 applies, and the memo stays where it is. The fund's own board observer already speaks to the CEO monthly, but counsel asks that any mention of licensing rest only on SourceX's published facts, with nothing from the memo, and the observer asks the CEO a single general question.
The customer clauses. The CEO of a 180-person outsourced support firm says its enterprise clients' contracts include confidentiality clauses. Trigger 5 applies, and so may trigger 6. The partner reads none of the contracts. They tell the CEO that SourceX's rights review covers customer and vendor contract limits, that client-owned material is usually not a fit on SourceX's own screening page, and that the company confirms its rights in its own agreement. The CEO asks the company's counsel and decides whether to apply.
Where the trigger sheet can fail
- Clauses incorporated by reference. The terms that bind you may sit in a document you were never sent. NVCA's model letter carries a footnote that, in our paraphrase, says that if the investor is not a party to the Investors' Rights Agreement, its confidentiality provisions need to be copied into the letter itself. Ask counsel which document governs before relying on the one in front of you.
- Knowledge you cannot unlearn. Even an ask rebuilt from public facts may be shaped by what you know. Counsel may prefer that a colleague without that knowledge make it, or that no one does.
- Terms that were never written down. Some confidences are oral. Treat them as written until counsel says otherwise.
- Several jurisdictions. A cross-border company may bring several legal systems into one question. That is counsel's work, not the sheet's.
- Gaps in the published documents. On withdrawal, later credit and anything else the terms leave open, SourceX decides.
For the related case of privileged material, see keeping privileged material out of referral discussions. The guides hub lists the neighboring boundary questions.
Next step
Refer a company. No cap on rewards. Default reward on a company's first qualifying transaction: the greater of $50,000 plus 5% and 15% of Actual Supplier Payout, with no cap; further qualifying transactions first agreed within 12 months of the first Closing pay 15%. Eligibility and payment conditions apply, including the USD 100,000 Minimum Transaction, and a signed Schedule A or addendum can differ. A lead, meeting or signature alone does not trigger payment.
Once counsel has cleared the route and the CEO wants the conversation, register as a partner if you have not signed yet, let the CEO check who qualifies for the company's side, and read the program terms together with section 4 of the sample agreement before the introduction goes in.
Clearing a referral through counsel is about your fund's duties to others; weighing SourceX itself as a possible investment is a separate decision, and the place to request materials for it is the SourceX investor overview.
This article is for information only and is not an offer to sell or a solicitation of an offer to buy securities. Any offering by SourceX is made only to verified accredited investors through its offering documents.